Anti-Diabetic Drugs Market 2019 Global Analysis, Opportunities and Forecast to 2025

Anti-Diabetic Drugs Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

Pune, India - March 22, 2019 /MarketersMedia/ —

Anti-Diabetic Drugs Market 2019

Wiseguyreports.Com adds “Anti-Diabetic Drugs Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Anti-Diabetic Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Anti-Diabetic Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. 
Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.  
Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk's diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk. 

The global Anti-Diabetic Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. 
This report focuses on Anti-Diabetic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Diabetic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. 
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered: 
Astra Zeneca 
Boehringer Ingelheim 
Eli Lilly 
Johnson & Johnson 
Merck 
Novartis 
Novo Nordisk 
Sanofi 
Teva Pharmaceutical Industries

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3825670-global-anti-diabetic-drugs-market-research-report-2019

Segment by Type 
Biguanides 
Sulfonylureas 
Meglitinides 
Thiazolidinediones 
Dipeptidyl Peptidase IV Inhibitors 
α-Glucosidase Inhibitors

Segment by Application 
Type I Diabetes 
Type II Diabetes 
Others

Segment by Regions
North America 
China 
India 
Japan 
Europe 

Key Stakeholders 
Anti-Diabetic Drugs Manufacturers 
Anti-Diabetic Drugs Distributors/Traders/Wholesalers 
Anti-Diabetic Drugs Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@  https://www.wiseguyreports.com/reports/3825670-global-anti-diabetic-drugs-market-research-report-2019

Major Key Points in Table of Content:

1 Anti-Diabetic Drugs Market Overview 
1.1 Product Overview and Scope of Anti-Diabetic Drugs 
1.2 Anti-Diabetic Drugs Segment by Type 
1.2.1 Global Anti-Diabetic Drugs Production Growth Rate Comparison by Type (2014-2025) 
1.2.2 Biguanides 
1.2.3 Sulfonylureas 
1.2.4 Meglitinides 
1.2.5 Thiazolidinediones 
1.2.6 Dipeptidyl Peptidase IV Inhibitors 
1.2.7 α-Glucosidase Inhibitors 
1.3 Anti-Diabetic Drugs Segment by Application 
1.3.1 Anti-Diabetic Drugs Consumption Comparison by Application (2014-2025) 
1.3.2 Type I Diabetes 
1.3.3 Type II Diabetes 
1.3.4 Others 
1.4 Global Anti-Diabetic Drugs Market by Region 
1.4.1 Global Anti-Diabetic Drugs Market Size Region 
1.4.2 North America Status and Prospect (2014-2025) 
1.4.3 Europe Status and Prospect (2014-2025) 
1.4.4 China Status and Prospect (2014-2025) 
1.4.5 Japan Status and Prospect (2014-2025) 
1.5 Global Anti-Diabetic Drugs Market Size 
1.5.1 Global Anti-Diabetic Drugs Revenue (2014-2025) 
1.5.2 Global Anti-Diabetic Drugs Production (2014-2025)

….

7 Company Profiles and Key Figures in Anti-Diabetic Drugs Business 
7.1 Astra Zeneca 
7.1.1 Astra Zeneca Anti-Diabetic Drugs Production Sites and Area Served 
7.1.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.1.3 Astra Zeneca Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.1.4 Main Business and Markets Served 
7.2 Boehringer Ingelheim 
7.2.1 Boehringer Ingelheim Anti-Diabetic Drugs Production Sites and Area Served 
7.2.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.2.4 Main Business and Markets Served 
7.3 Eli Lilly 
7.3.1 Eli Lilly Anti-Diabetic Drugs Production Sites and Area Served 
7.3.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.3.3 Eli Lilly Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.3.4 Main Business and Markets Served 
7.4 Johnson & Johnson 
7.4.1 Johnson & Johnson Anti-Diabetic Drugs Production Sites and Area Served 
7.4.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.4.3 Johnson & Johnson Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.4.4 Main Business and Markets Served 
7.5 Merck 
7.5.1 Merck Anti-Diabetic Drugs Production Sites and Area Served 
7.5.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.5.3 Merck Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.5.4 Main Business and Markets Served 
7.6 Novartis 
7.6.1 Novartis Anti-Diabetic Drugs Production Sites and Area Served 
7.6.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.6.3 Novartis Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.6.4 Main Business and Markets Served 
7.7 Novo Nordisk 
7.7.1 Novo Nordisk Anti-Diabetic Drugs Production Sites and Area Served 
7.7.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.7.3 Novo Nordisk Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.7.4 Main Business and Markets Served 
7.8 Sanofi 
7.8.1 Sanofi Anti-Diabetic Drugs Production Sites and Area Served 
7.8.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.8.3 Sanofi Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.8.4 Main Business and Markets Served 
7.9 Teva Pharmaceutical Industries 
7.9.1 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production Sites and Area Served 
7.9.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.9.4 Main Business and Markets Served

Continued….

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: 841 198 5042
Website: https://www.wiseguyreports.com/reports/3825670-global-anti-diabetic-drugs-market-research-report-2019

Source URL: https://marketersmedia.com/anti-diabetic-drugs-market-2019-global-analysis-opportunities-and-forecast-to-2025/494776

Source: MarketersMedia

Release ID: 494776

Latest News

UK's May tweaks Brexit deal in last-ditch bid to win support

May 22, 2019

LONDON — British Prime Minister Theresa May secured backing from her Cabinet Tuesday for tweaks to her proposed European Union divorce terms that she hopes can finally get Parliament's approval for her thrice-rejected Brexit deal. The Cabinet met for three hours to work out details of what May has called a "bold offer" to win support for her Brexit agreement. May was due to give details of what's being billed as her "new deal" in a speech later Tuesday. But it's unlikely changes agreed by the government — whose members are divided over the terms of Britain's EU departure —...

Uncertainty looms over UK as Brexit compromise talks fail

May 22, 2019

LONDON — Talks between Britain's Conservative government and the opposition Labour Party seeking a compromise over Brexit broke down without agreement Friday, plunging the country back into a morass of uncertainty over its departure from the European Union. Each side blamed the other for the collapse. Labour Party leader Jeremy Corbyn said the talks with Prime Minister Theresa May's government had "gone as far as they can." "We have been unable to bridge important policy gaps between us," Corbyn said in a letter to May released by Labour. And with May set to announce within weeks that she plans to...

UEFA investigators send Man City case to judges for verdict

May 22, 2019

NYON, Switzerland — UEFA says its club finance investigators have sent their Manchester City file to independent judges for a verdict. The English champion faces a one-year ban from the Champions League, potentially next season. The club finance panel opened its formal case against City in March "for potential breaches of Financial Fair Play (FFP) regulations that were made public in various media outlets." Internal documents about City's business and emails between club executives were published in the Football Leaks series led by German magazine Der Spiegel. The revelations suggested City officials deceived UEFA over several years, including by disguising...

Stockpiling boosted UK economy ahead of initial Brexit date

May 22, 2019

LONDON — The British economy expanded by a solid quarterly rate of 0.5% in the first three months of the year as firms geared up for the long-anticipated Brexit date. However, that boon is set to diminish in coming months and growth is expected to ease as the country hurtles toward its next Brexit date. Much of the growth reported Friday by the Office for National Statistics appears to have been due to firms stockpiling raw materials and products ahead of Britain's scheduled departure from the EU on March 29, a deadline that's since been extended to Oct. 31. Overall...

Singapore reportedly criminalizes publication of fake news

May 22, 2019

SINGAPORE — Singapore reportedly has passed a law criminalizing publication of fake news and allowing the government to block and order the removal of such content. The Protection from Online Falsehoods and Manipulation Bill passed Wednesday night by a vote of 72-9, a lawmaker with the opposition Worker's Party, Daniel Goh, said on Twitter. The law bans falsehoods that are prejudicial to Singapore or likely to influence elections and requires service providers to remove such content or allows the government to block it. Offenders could face a jail term of up to 10 years and hefty fines. Opponents in Parliament...

Financial Markets

Market Sanctum is one of the world’s leading news sources for the currency trading community. Our analysts report on the latest changes in the current market, providing in-depth analysis.

Contact us: sales[at]marketsanctum.com